Newron Pharmaceuticals
NWRN.SW
#8290
Rank
S$0.23 B
Marketcap
$12.21
Share price
-0.74%
Change (1 day)
78.19%
Change (1 year)

Newron Pharmaceuticals (NWRN.SW) - Cash on Hand

Cash on Hand as of December 2023 : S$18.86 Million

According to Newron Pharmaceuticals's latest financial reports the company has S$18.86 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Newron Pharmaceuticals - Cash on Hand chart (from 2009 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$18.39 M-43.83%
2022-12-31S$32.74 M-38.17%
2021-12-31S$52.96 M4.16%
2020-12-31S$50.85 M-14.03%
2019-12-31S$59.14 M-13.7%
2018-12-31S$68.53 M-28.92%
2017-12-31S$96.41 M36.3%
2016-12-31S$70.74 M11.74%
2015-12-31S$63.3 M53.27%
2014-12-31S$41.3 M28.11%
2013-12-31S$32.24 M-31.84%
2012-12-31S$47.3 M424.07%
2011-12-31S$9.02 M-34.86%
2010-12-31S$13.85 M-71.64%
2009-12-31S$48.86 M-40.77%
2008-12-31S$82.5 M-37.83%
2007-12-31S$0.13 B-12.28%
2006-12-31S$0.15 B339.62%
2005-12-31S$34.4 M